UK markets closed

Madrigal Pharmaceuticals, Inc. (MDGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
201.23+0.16 (+0.08%)
As of 12:49PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
272,350
272,350
245,441
205,164
184,809
Selling general and administrative
108,146
108,146
48,130
37,318
21,864
Total operating expenses
380,496
380,496
293,571
242,482
206,673
Operating income or loss
-380,496
-380,496
-293,571
-242,482
-206,673
Interest expense
12,712
12,712
3,964
0
-
Total other income/expenses net
-
-
-
273
100
Income before tax
-373,630
-373,630
-295,350
-241,846
-202,244
Income from continuing operations
-373,630
-373,630
-295,350
-241,846
-202,244
Net income
-373,630
-373,630
-295,350
-241,846
-202,244
Net income available to common shareholders
-373,630
-373,630
-295,350
-241,846
-202,244
Basic EPS
-19.25
-
-17.23
-14.63
-13.09
Diluted EPS
-19.25
-
-17.23
-14.63
-13.09
Basic average shares
18,054
-
17,137
16,535
15,447
Diluted average shares
18,054
-
17,137
16,535
15,447